Literature DB >> 13680399

Aetiology and clinical presentation of mild community-acquired bacterial pneumonia.

B Beović1, B Bonac, D Kese, T Avsic-Zupanc, S Kreft, G Lesnicar, J Gorisek-Rebersek, L Rezar, S Letonja.   

Abstract

A prospective study was initiated to analyse the bacterial aetiology and clinical picture of mild community-acquired pneumonia in Slovenia using the previously described Pneumonia Severity Index. Radiographically confirmed cases of pneumonia in patients treated with oral antibiotics in seven study centres were included. An aetiological diagnosis was attempted using culture of blood and sputum, urinary antigen testing for Streptococcus pneumoniae and Legionella pneumophila, and antibody testing for Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in paired serum samples. One hundred thirteen patients were evaluable for clinical presentation and 109 for aetiological diagnosis. At least one pathogen was detected in 62.4% patients. The most common causative agents were Mycoplasma pneumoniae in 24.8%, Chlamydia pneumoniae in 21.1%, and Streptococcus pneumoniae in 13.8% of patients. Dual infection was detected in 8.3% of patients. Most patients suffered from cough, fatigue, and fever. Patients with atypical aetiology of pneumonia differed from those with typical bacterial pneumonia or pneumonia of unknown aetiology in age, presence of dyspnea, and bronchial breathing on lung auscultation. Patients with pneumococcal, chlamydial, and mycoplasmal infections differed in age, risk class, presence of dyspnea, bronchial breathing, and proteinuria. There was an overlap of other clinical symptoms, underlying conditions, and laboratory and radiographic findings among the groups of patients classified by aetiology. Since patients with mild community-acquired pneumonia exhibit similar clinical characteristics and, moreover, since a substantial proportion of cases are attributable to atypical bacteria, broad-spectrum antibiotic treatment seems to be recommended.

Entities:  

Mesh:

Year:  2003        PMID: 13680399     DOI: 10.1007/s10096-003-0997-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Authors:  S F Dowell; R W Peeling; J Boman; G M Carlone; B S Fields; J Guarner; M R Hammerschlag; L A Jackson; C C Kuo; M Maass; T O Messmer; D F Talkington; M L Tondella; S R Zaki
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

3.  Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples.

Authors:  J Domínguez; N Galí; S Blanco; P Pedroso; C Prat; L Matas; V Ausina
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

4.  Microbial aetiology of community-acquired pneumonia in hospitalised patients.

Authors:  M Socan; N Marinic-Fiser; A Kraigher; A Kotnik; M Logar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-11       Impact factor: 3.267

5.  Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.

Authors:  P P Gleason; T P Meehan; J M Fine; D H Galusha; M J Fine
Journal:  Arch Intern Med       Date:  1999-11-22

6.  Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.

Authors:  J E Stahl; M Barza; J DesJardin; R Martin; M H Eckman
Journal:  Arch Intern Med       Date:  1999-11-22

7.  Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients.

Authors:  D Lieberman; M Ben-Yaakov; Z Lazarovich; A Porath; F Schlaeffer; D Lieberman; M Leinonen; P Saikku; O Horovitz; I Boldur
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

8.  Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience.

Authors:  R Monno; D De Vito; G Losito; G Sibilio; A Costi; L Fumarola; A D'Aprile; P Marcuccio
Journal:  J Infect       Date:  2002-10       Impact factor: 6.072

9.  Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae specific immunoglobulin M.

Authors:  L Hirschberg; A Krook; C A Pettersson; T Vikerfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

10.  Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

Authors:  J Blanquer; R Blanquer; R Borrás; D Nauffal; P Morales; R Menéndez; I Subías; L Herrero; J Redón; J Pascual
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

View more
  12 in total

1.  Ambulatory community-acquired pneumonia: the predominance of atypical pathogens.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10       Impact factor: 3.267

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

Review 3.  Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.

Authors:  Christian Marchello; Ariella Perry Dale; Thuy Nhu Thai; Duk Soo Han; Mark H Ebell
Journal:  Ann Fam Med       Date:  2016-11       Impact factor: 5.166

Review 4.  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

Authors:  M H Rozenbaum; P Pechlivanoglou; T S van der Werf; J R Lo-Ten-Foe; M J Postma; E Hak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-14       Impact factor: 3.267

5.  Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study.

Authors:  Jang Wook Sohn; Seung Chul Park; Young-Hwa Choi; Heung Jeong Woo; Yong Kyun Cho; Jin Soo Lee; Hee-Sun Sim; Min Ja Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

Review 6.  Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  L Hogerwerf; B DE Gier; B Baan; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2017-09-26       Impact factor: 4.434

7.  Dipstick proteinuria level is significantly associated with pre-morbid and in-hospital functional status among hospitalized older adults: a preliminary study.

Authors:  Chia-Ter Chao; Hung-Bin Tsai; Chih-Kang Chiang; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

Review 8.  The atypical pneumonias: clinical diagnosis and importance.

Authors:  B A Cunha
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

Review 9.  [Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features].

Authors:  F Philippart
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

Review 10.  Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

Authors:  Maria A Said; Hope L Johnson; Bareng A S Nonyane; Maria Deloria-Knoll; Katherine L O'Brien; Felipe Andreo; Bojana Beovic; Silvia Blanco; Wim G Boersma; David R Boulware; Jay C Butler; Jordi Carratalà; Feng-Yee Chang; Patrick G P Charles; Alejandro A Diaz; Jose Domínguez; Naomi Ehara; Henrik Endeman; Vicenç Falcó; Miquel Falguera; Kiyoyasu Fukushima; Carolina Garcia-Vidal; Daniel Genne; Igor A Guchev; Felix Gutierrez; Susanne S Hernes; Andy I M Hoepelman; Ulla Hohenthal; Niclas Johansson; Vitezslav Kolek; Roman S Kozlov; Tsai-Ling Lauderdale; Ivana Mareković; Mar Masiá; Matta A Matta; Òscar Miró; David R Murdoch; Eric Nuermberger; Richard Paolini; Rafael Perelló; Dominic Snijders; Vanda Plečko; Roger Sordé; Kristoffer Strålin; Menno M van der Eerden; Angel Vila-Corcoles; James P Watt
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.